Search Results - "Barth, Anneliese"
-
1
Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future
Published in Biology of blood and marrow transplantation (01-07-2019)“…•Several factors, including donor type, particular mucopolysaccharidoses (MPS) disorder, disease stage, clinical severity, preconditioning regimen, and…”
Get full text
Journal Article -
2
Long-term impact of early initiation of enzyme replacement therapy in 34 MPS VI patients: A resurvey study
Published in Molecular genetics and metabolism (01-05-2021)“…Patients with mucopolysaccharidosis type VI (MPS VI) present with a wide range of disease severity and clinical manifestations, with significant functional…”
Get full text
Journal Article -
3
Early hematopoietic stem cell transplantation in a patient with severe mucopolysaccharidosis II: A 7 years follow-up
Published in Molecular genetics and metabolism reports (01-09-2017)“…Mucopolysaccharidosis type II (MPS II - Hunter syndrome) is an X-linked lysosomal storage disorder caused by a deficiency in the enzyme iduronate-2 sulfatase…”
Get full text
Journal Article -
4
Alternative laronidase dose regimen for patients with mucopolysaccharidosis I: a multinational, retrospective, chart review case series
Published in Orphanet journal of rare diseases (29-04-2016)“…Enzyme replacement therapy (ERT) with laronidase (recombinant human α-L-iduronidase, Aldurazyme®) is indicated for non-neurological signs and symptoms of…”
Get full text
Journal Article -
5
Laryngeal, Tracheal, and Bronchial Disease in the Mucopolysaccharidoses: Endoscopic Study
Published in Diagnostics (Basel) (10-01-2020)“…Mucopolysaccharidoses (MPS) are genetically determined diseases, leading to a deficiency of enzymes in the glycosaminoglycan (GAG) degradation pathway. The…”
Get full text
Journal Article -
6
Mucopolysaccharidosis Type I
Published in Diagnostics (Basel) (16-03-2020)“…Mucopolysaccharidosis type I (MPS I) is caused by the deficiency of α-l-iduronidase, leading to the storage of dermatan and heparan sulfate. There is a broad…”
Get full text
Journal Article -
7
Hematopoietic Stem Cell Transplantation in Mucopolysaccharidosis Type II
Published in Journal of inborn errors of metabolism and screening (01-05-2018)“…Mucopolysaccharidosis II (MPS II—Hunter syndrome) is an X-linked lysosomal storage disorder caused by a deficiency in iduronate-2 sulfatase. Enzyme replacement…”
Get full text
Journal Article -
8
Otolaryngologists and the Early Diagnosis of Mucopolysaccharidoses: A Cross-Sectional Study
Published in Diagnostics (Basel) (13-11-2019)“…Mucopolysaccharidoses (MPS) are a group of inborn errors of metabolism with an aggressive and usually fatal course. Therefore, early treatment is essential…”
Get full text
Journal Article -
9
Transition to home infusion in Pompe disease in Brazil: Safety of the regimen during the COVID-19 pandemic and thereafter
Published in Molecular genetics and metabolism (01-02-2023)Get full text
Journal Article -
10
Challenges and hurdles to cope with Pompe disease in the Brazilian Unified Health System (SUS) frame: Lessons learned from a series of 19 patients from a national Rare Disease Reference Center in the state of Rio de Janeiro, Brazil
Published in Molecular genetics and metabolism (01-02-2023)Get full text
Journal Article -
11
-
12
Need leads to change: Transition to home infusion in Pompe disease in Brazil in the COVID-19 pandemic
Published in Molecular genetics and metabolism (01-02-2021)Get full text
Journal Article -
13
Marfan syndrome: importance of family history - case report
Published in Residência Pediátrica (2023)“…We describe a case of Marfan syndrome, referred for evaluation due to an important family history of sudden death. In the first evaluation, he presented…”
Get full text
Journal Article -
14
Hematopoietic Stem Cell Transplantation in Mucopolysaccharidosis Type II: A Literature Review and Critical Analysis
Published in Journal of Inborn Errors of Metabolism and Screening (30-05-2018)“…Mucopolysaccharidosis II (MPS II—Hunter syndrome) is an X-linked lysosomal storage disorder caused by a deficiency in iduronate-2 sulfatase. Enzyme replacement…”
Get full text
Book Review Journal Article -
15
Mucopolysaccharidoses and laryngeal, tracheal and bronchial disease: Type-specific abnormalities and long-term implications
Published in Molecular genetics and metabolism (01-02-2019)“…Airway complications are among the most common early and lethal manifestations of mucopolysaccharidoses (MPS). Not much is known, however, on the anatomical…”
Get full text
Journal Article -
16
-
17
Bone/joint abnormalities in children/adolescents: A screening protocol for mucopolysaccharidosis
Published in Molecular genetics and metabolism (01-02-2019)“…Mucopolysaccharidoses (MPS) are under-diagnosed, especially milder forms. A screening protocol was tested at the National Institute of Orthopedics in Rio de…”
Get full text
Journal Article -
18
Enzyme replacement therapy in mucopolysaccharidosis type II with alternative dosing 1mg/kg idursulfase in every other week infusions
Published in Molecular genetics and metabolism (01-02-2019)“…Enzyme replacement therapy for mucopolysaccharidosis II (MPS II) with Idursulfase (ElapraseR) has proven effective in reducing urinary glycosaminoglycan (uGAG)…”
Get full text
Journal Article -
19
-
20
Spinal cord occupation ratio (SCOR) and its application in the diagnosis of cervical spinal cord compression in Mucopolysaccharidoses
Published in Journal of inborn errors of metabolism and screening (2022)“…Abstract Introduction Mucopolysaccharidoses (MPS) can lead to cervical spinal cord compression (SCC). Diagnostic scores for SCC in MPS use the obliteration of…”
Get full text
Journal Article